The mucosal atomization devices market size has grown rapidly in recent years. It will grow from $0.92 billion in 2025 to $1.02 billion in 2026 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to increasing use of nasal drug delivery methods, rising emergency medical interventions, growth of outpatient treatment settings, availability of atomization-based therapies, increased clinical awareness of mucosal delivery.
The mucosal atomization devices market size is expected to see rapid growth in the next few years. It will grow to $1.52 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing demand for non-invasive drug administration, rising adoption in emergency and anesthesia care, expansion of home healthcare usage, growing focus on infection control, increasing development of portable medical delivery devices. Major trends in the forecast period include increasing adoption of needle-free drug delivery devices, rising demand for rapid-acting emergency medications, growing use of single-use atomization devices, expansion of portable atomization solutions, enhanced focus on patient comfort and safety.
The increasing prevalence of allergic rhinitis is anticipated to support the growth of the mucosal atomization devices market in the coming years. Allergic rhinitis is an inflammatory disorder of the nasal passages triggered by an immune response to airborne allergens such as pollen, dust mites, and animal dander. Its rising incidence is primarily associated with worsening air quality and higher exposure to environmental allergens, as rapid urbanization and industrial activity lead to elevated levels of particulate matter and pollutants that provoke and intensify allergic reactions in vulnerable populations. As the number of affected individuals grows, demand increases for effective nasal drug delivery solutions that can deliver medication quickly and directly to the nasal mucosa, offering rapid relief from symptoms including nasal congestion, sneezing, and inflammation. For example, in January 2024, according to the UK Health Security Agency, consultation rates for allergic rhinitis rose significantly during week 23, corresponding with high grass pollen levels and warmer weather conditions. The highest consultation rates were recorded among individuals aged 5-14 years and 15-44 years, with rates also exceeding seasonal baseline levels in London, the South East, and the South West regions. As a result, the growing burden of allergic rhinitis is contributing to the expansion of the mucosal atomization devices market.
Major companies in the mucosal atomization device market are concentrating on developing technological advancements such as metal-free nasal spray pumps to enhance the patient experience. For example, in January 2023, Aptar Pharma, a US-based pharmaceutical company, introduced the APF Futurity. This metal-free, multidose nasal spray pump is designed for delivering nasal saline and similar over-the-counter (OTC) formulations. The APF Futurity is Aptar Pharma's first highly recyclable nasal spray pump, having received a Class AA certification from cyclos-HTP for recycling in Europe. Constructed from polyolefin materials without any metal components or recycling disruptors, the APF Futurity reduces separation efforts in recycling streams and supports the production of higher quality recyclates.
In October 2024, Aptar Pharma Inc., a United States-based healthcare technology company, acquired all device technology assets of SipNose Nasal Delivery Systems Ltd. for an undisclosed consideration. Through this acquisition, Aptar Pharma sought to enhance its intranasal drug delivery portfolio, with particular emphasis on strengthening its nose-to-brain delivery capabilities by incorporating SipNose’s advanced technologies. The transaction is expected to accelerate the development of innovative therapies for central nervous system and systemic conditions, reinforce Aptar Pharma’s technological leadership in precision nasal delivery, and improve its competitive positioning in the global pharmaceutical drug delivery landscape. SipNose Nasal Delivery Systems Ltd. is an Israel-based medical technology company focused on the development of specialized intranasal delivery platforms.
Major companies operating in the mucosal atomization devices market are Teleflex Incorporated, Cook Medical LLC, Pulmodyne Inc., Life-Assist Inc., Vyaire Medical Inc., Mercury Medical, SunMed LLC, Salter Labs, Armstrong Medical Industries Inc., VBM Medizintechnik GmbH, Intersurgical Ltd., Flexicare Medical Limited, Medovations Inc., Atom Medical Corporation, BLS Systems Limited, Dali Medical Devices Co. Ltd., Trudell Medical International, PARI GmbH, Omron Healthcare Inc., Drive Medical Holdings LLC, Laerdal Medical AS.
North America was the largest region in the mucosal atomization devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mucosal atomization devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the mucosal atomization devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the mucosal atomization devices market by increasing costs of imported medical-grade plastics, precision nozzles, pumps, and electronic components used in atomization systems. Healthcare providers in North America and Europe are most affected due to reliance on imported device components, while Asia-Pacific faces higher production costs. These tariffs are increasing device prices and procurement costs. However, they are also driving local manufacturing, regional supplier development, and innovation in simplified and disposable atomization devices.
The mucosal atomization devices market research report is one of a series of new reports that provides mucosal atomization devices market statistics, including mucosal atomization devices industry global market size, regional shares, competitors with a mucosal atomization devices market share, detailed mucosal atomization devices market segments, market trends and opportunities, and any further data you may need to thrive in the mucosal atomization devices industry. This mucosal atomization devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Mucosal atomization devices are designed to administer medication through the nostrils, ensuring reliable topical solution atomization across the nasal and oropharyngeal mucous membranes. These devices are particularly effective in delivering atomized medication to mucosal surfaces in the nasal, oral, laryngeal, tracheal, and lung regions.
The primary types of mucosal atomization devices include nasal atomization devices, fibre-optic atomization devices, laryngotracheal atomization devices, and bottle atomizer devices. Nasal atomization devices provide a painless and safe method for swiftly delivering fast-acting drugs that efficiently penetrate mucosal membranes and enter the bloodstream. Various mucosal atomization device technologies include gas-propelled atomization devices and electrical atomization devices. These devices find application in diverse healthcare settings, including hospitals, ambulatory surgical centers, and specialized clinics.
The mucosal atomization devices market consists of sales of 3cc Syringe and VetJet. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The mucosal atomization devices market size is expected to see rapid growth in the next few years. It will grow to $1.52 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing demand for non-invasive drug administration, rising adoption in emergency and anesthesia care, expansion of home healthcare usage, growing focus on infection control, increasing development of portable medical delivery devices. Major trends in the forecast period include increasing adoption of needle-free drug delivery devices, rising demand for rapid-acting emergency medications, growing use of single-use atomization devices, expansion of portable atomization solutions, enhanced focus on patient comfort and safety.
The increasing prevalence of allergic rhinitis is anticipated to support the growth of the mucosal atomization devices market in the coming years. Allergic rhinitis is an inflammatory disorder of the nasal passages triggered by an immune response to airborne allergens such as pollen, dust mites, and animal dander. Its rising incidence is primarily associated with worsening air quality and higher exposure to environmental allergens, as rapid urbanization and industrial activity lead to elevated levels of particulate matter and pollutants that provoke and intensify allergic reactions in vulnerable populations. As the number of affected individuals grows, demand increases for effective nasal drug delivery solutions that can deliver medication quickly and directly to the nasal mucosa, offering rapid relief from symptoms including nasal congestion, sneezing, and inflammation. For example, in January 2024, according to the UK Health Security Agency, consultation rates for allergic rhinitis rose significantly during week 23, corresponding with high grass pollen levels and warmer weather conditions. The highest consultation rates were recorded among individuals aged 5-14 years and 15-44 years, with rates also exceeding seasonal baseline levels in London, the South East, and the South West regions. As a result, the growing burden of allergic rhinitis is contributing to the expansion of the mucosal atomization devices market.
Major companies in the mucosal atomization device market are concentrating on developing technological advancements such as metal-free nasal spray pumps to enhance the patient experience. For example, in January 2023, Aptar Pharma, a US-based pharmaceutical company, introduced the APF Futurity. This metal-free, multidose nasal spray pump is designed for delivering nasal saline and similar over-the-counter (OTC) formulations. The APF Futurity is Aptar Pharma's first highly recyclable nasal spray pump, having received a Class AA certification from cyclos-HTP for recycling in Europe. Constructed from polyolefin materials without any metal components or recycling disruptors, the APF Futurity reduces separation efforts in recycling streams and supports the production of higher quality recyclates.
In October 2024, Aptar Pharma Inc., a United States-based healthcare technology company, acquired all device technology assets of SipNose Nasal Delivery Systems Ltd. for an undisclosed consideration. Through this acquisition, Aptar Pharma sought to enhance its intranasal drug delivery portfolio, with particular emphasis on strengthening its nose-to-brain delivery capabilities by incorporating SipNose’s advanced technologies. The transaction is expected to accelerate the development of innovative therapies for central nervous system and systemic conditions, reinforce Aptar Pharma’s technological leadership in precision nasal delivery, and improve its competitive positioning in the global pharmaceutical drug delivery landscape. SipNose Nasal Delivery Systems Ltd. is an Israel-based medical technology company focused on the development of specialized intranasal delivery platforms.
Major companies operating in the mucosal atomization devices market are Teleflex Incorporated, Cook Medical LLC, Pulmodyne Inc., Life-Assist Inc., Vyaire Medical Inc., Mercury Medical, SunMed LLC, Salter Labs, Armstrong Medical Industries Inc., VBM Medizintechnik GmbH, Intersurgical Ltd., Flexicare Medical Limited, Medovations Inc., Atom Medical Corporation, BLS Systems Limited, Dali Medical Devices Co. Ltd., Trudell Medical International, PARI GmbH, Omron Healthcare Inc., Drive Medical Holdings LLC, Laerdal Medical AS.
North America was the largest region in the mucosal atomization devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mucosal atomization devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the mucosal atomization devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the mucosal atomization devices market by increasing costs of imported medical-grade plastics, precision nozzles, pumps, and electronic components used in atomization systems. Healthcare providers in North America and Europe are most affected due to reliance on imported device components, while Asia-Pacific faces higher production costs. These tariffs are increasing device prices and procurement costs. However, they are also driving local manufacturing, regional supplier development, and innovation in simplified and disposable atomization devices.
The mucosal atomization devices market research report is one of a series of new reports that provides mucosal atomization devices market statistics, including mucosal atomization devices industry global market size, regional shares, competitors with a mucosal atomization devices market share, detailed mucosal atomization devices market segments, market trends and opportunities, and any further data you may need to thrive in the mucosal atomization devices industry. This mucosal atomization devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Mucosal atomization devices are designed to administer medication through the nostrils, ensuring reliable topical solution atomization across the nasal and oropharyngeal mucous membranes. These devices are particularly effective in delivering atomized medication to mucosal surfaces in the nasal, oral, laryngeal, tracheal, and lung regions.
The primary types of mucosal atomization devices include nasal atomization devices, fibre-optic atomization devices, laryngotracheal atomization devices, and bottle atomizer devices. Nasal atomization devices provide a painless and safe method for swiftly delivering fast-acting drugs that efficiently penetrate mucosal membranes and enter the bloodstream. Various mucosal atomization device technologies include gas-propelled atomization devices and electrical atomization devices. These devices find application in diverse healthcare settings, including hospitals, ambulatory surgical centers, and specialized clinics.
The mucosal atomization devices market consists of sales of 3cc Syringe and VetJet. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Mucosal Atomization Devices Market Characteristics
3. Mucosal Atomization Devices Market Supply Chain Analysis
4. Global Mucosal Atomization Devices Market Trends and Strategies
5. Mucosal Atomization Devices Market Analysis of End Use Industries
7. Global Mucosal Atomization Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Mucosal Atomization Devices Total Addressable Market (TAM) Analysis for the Market
9. Mucosal Atomization Devices Market Segmentation
10. Mucosal Atomization Devices Market Regional and Country Analysis
11. Asia-Pacific Mucosal Atomization Devices Market
12. China Mucosal Atomization Devices Market
13. India Mucosal Atomization Devices Market
14. Japan Mucosal Atomization Devices Market
15. Australia Mucosal Atomization Devices Market
16. Indonesia Mucosal Atomization Devices Market
17. South Korea Mucosal Atomization Devices Market
18. Taiwan Mucosal Atomization Devices Market
19. South East Asia Mucosal Atomization Devices Market
20. Western Europe Mucosal Atomization Devices Market
21. UK Mucosal Atomization Devices Market
22. Germany Mucosal Atomization Devices Market
23. France Mucosal Atomization Devices Market
24. Italy Mucosal Atomization Devices Market
25. Spain Mucosal Atomization Devices Market
26. Eastern Europe Mucosal Atomization Devices Market
27. Russia Mucosal Atomization Devices Market
28. North America Mucosal Atomization Devices Market
29. USA Mucosal Atomization Devices Market
30. Canada Mucosal Atomization Devices Market
31. South America Mucosal Atomization Devices Market
32. Brazil Mucosal Atomization Devices Market
33. Middle East Mucosal Atomization Devices Market
34. Africa Mucosal Atomization Devices Market
36. Mucosal Atomization Devices Market Competitive Landscape and Company Profiles
37. Mucosal Atomization Devices Market Other Major and Innovative Companies
40. Mucosal Atomization Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Mucosal Atomization Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses mucosal atomization devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for mucosal atomization devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mucosal atomization devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Nasal Atomization Devices; Laryngo-Tracheal Atomization Devices2) By Technology: Gas-Propelled Atomization Devices; Electrical Atomization Devices
3) By End User: Hospitals; Ambulatory Surgical Centers; Specialized Clinics
Subsegments:
1) By Nasal Atomization Devices: Handheld Nasal Sprays; Mechanical Nasal Atomizers; Electric Nasal Atomizers2) By Laryngo-Tracheal Atomization Devices: Jet Nebulizers; Ultrasonic Nebulizers; Portable Laryngo-Tracheal Atomizers
Companies Mentioned: Teleflex Incorporated; Cook Medical LLC; Pulmodyne Inc.; Life-Assist Inc.; Vyaire Medical Inc.; Mercury Medical; SunMed LLC; Salter Labs; Armstrong Medical Industries Inc.; VBM Medizintechnik GmbH; Intersurgical Ltd.; Flexicare Medical Limited; Medovations Inc.; Atom Medical Corporation; BLS Systems Limited; Dali Medical Devices Co. Ltd.; Trudell Medical International; PARI GmbH; Omron Healthcare Inc.; Drive Medical Holdings LLC; Laerdal Medical AS
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Mucosal Atomization Devices market report include:- Teleflex Incorporated
- Cook Medical LLC
- Pulmodyne Inc.
- Life-Assist Inc.
- Vyaire Medical Inc.
- Mercury Medical
- SunMed LLC
- Salter Labs
- Armstrong Medical Industries Inc.
- VBM Medizintechnik GmbH
- Intersurgical Ltd.
- Flexicare Medical Limited
- Medovations Inc.
- Atom Medical Corporation
- BLS Systems Limited
- Dali Medical Devices Co. Ltd.
- Trudell Medical International
- PARI GmbH
- Omron Healthcare Inc.
- Drive Medical Holdings LLC
- Laerdal Medical AS
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.02 Billion |
| Forecasted Market Value ( USD | $ 1.52 Billion |
| Compound Annual Growth Rate | 10.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
